Abstract

Carpal Tunnel Syndrome (CTS) is a prevalent condition caused by compression of the median nerve at the wrist, leading to symptoms such as pain, numbness, tingling, and weakness in the hand. While traditional treatments like corticosteroid injections, wrist splinting, and surgical decompression have been widely used, emerging therapies are gaining attention for their potential to provide effective alternatives, particularly for patients who do not respond well to conventional approaches. This review explores the latest advancements in the treatment of CTS, including platelet-rich plasma (PRP) therapy, nerve hydrodissection, ultrasound-guided injections, stem cell therapy, and laser therapy. Early studies suggest that these therapies may offer long-term relief, improve nerve function, and reduce inflammation, with fewer side effects compared to traditional treatments. The mechanisms of action for each therapy, patient selection, and clinical outcomes are discussed, along with the potential benefits and challenges. Although promising, more robust, large-scale studies are required to determine the efficacy, safety, and long-term benefits of these emerging therapies. This article provides an overview of the current state of emerging treatments and highlights their potential to revolutionize the management of Carpal Tunnel Syndrome in the coming years.